INTRODUCTION {#s1}
============

The mammalian gastrointestinal (GI) tract harbors a vast density and diversity of microorganisms that can provide protection against pathogen colonization. *Escherichia coli* is one of the first members to colonize infants and establishes as a life-long resident of the normal intestinal microbiota in humans ([@DMM035063C22]). Non-pathogenic *E*. *coli* strains provide the host benefits such as vitamin K and B~12~ ([@DMM035063C9]); however, certain *E*. *coli* strains can cause disease. Enterohemorrhagic *E. coli* (EHEC) is a pathotype of diarrheagenic *E*. *coli*, which causes mild to severe bloody diarrhea in humans that can progress to hemolytic uremic syndrome ([@DMM035063C18]). EHEC strains carry genes for Shiga toxin and the locus of enterocyte effacement (LEE), including the type III secretion system and major adherence factor intimin ([@DMM035063C24]; [@DMM035063C68]). In the US, O157:H7 EHEC is the most common serotype associated with EHEC infections in humans ([@DMM035063C31]). Ruminants, including cattle, are the primary reservoir for O157 EHEC ([@DMM035063C33]), and the pathogen is commonly transmitted to humans by direct contact with ruminants or through ingestion of fecally contaminated food or water ([@DMM035063C15]). After ingestion, EHEC colonizes colonic epithelial cells and carries both inflammatory stimulators (e.g. endotoxin, flagellin, Shiga toxin) and suppressors (e.g. type III secreted effectors) ([@DMM035063C57]). O157 EHEC colonization and presentation of disease symptoms typically occurs within 1-2 weeks after ingestion ([@DMM035063C72]). Children under 5 years old are more likely to develop severe disease following infection with EHEC ([@DMM035063C18]). A few studies have determined that the shedding duration of O157 EHEC in children can last over 100 days, with most reporting a mean duration of 1 month ([@DMM035063C51]; [@DMM035063C56]; [@DMM035063C63]). Adults may also develop severe disease but, in some adults, such as cattle farm and processing workers, asymptomatic colonization with EHEC has been reported ([@DMM035063C37]; [@DMM035063C64]).

Animal models to study *E*. *coli* have limitations in establishing intestinal colonization. Large animal models such as baboons ([@DMM035063C73]), greyhounds ([@DMM035063C58]), monkeys ([@DMM035063C43]) and pigs ([@DMM035063C25], [@DMM035063C26]; [@DMM035063C75], [@DMM035063C76]) have poor scalability and require extensive veterinary expertise, labor and funding. Mice serve as an attractive model organism due to their size, short generation time and characterized genetics. However, conventionally reared (CONV) adult mice are often naturally resistant to *E. coli* colonization ([@DMM035063C59]). To overcome resistance, streptomycin has been used to suppress facultative anaerobic bacteria, allowing for streptomycin-resistant *E*. *coli* to colonize ([@DMM035063C2]; [@DMM035063C47]; [@DMM035063C48]). Streptomycin-treated mice have a variable microbiota and require generation of streptomycin-resistant *E. coli* mutants, which can affect expression of bacterial virulence factors ([@DMM035063C13]). Other studies have used germ-free mouse models to study *E*. *coli* colonization ([@DMM035063C30]; [@DMM035063C71]), but these animals lack the influence of a microbiota and have underdeveloped mucosal immune systems and altered intestinal morphology ([@DMM035063C38]). A few studies have used CONV mouse models, but administration of a high dose \[≥10^9^ colony-forming units (CFU)\] is required and variable colonization was observed ([@DMM035063C53]; [@DMM035063C55]). Thus, developing reliable animal models to study *E*. *coli* intestinal colonization remains of utmost importance.

The altered Schaedler flora (ASF) is a set of eight bacterial species that can be stably maintained in gnotobiotic mice over many generations ([@DMM035063C77]). ASF mice develop normal GI function and immune systems ([@DMM035063C29]; [@DMM035063C60]). Previously, it was demonstrated that, without the use of antibiotics, adherent and invasive *E. coli* colonized C3H/HeN ASF mice ([@DMM035063C36]) and *Salmonella enterica* colonized C57BL/6 ASF mice ([@DMM035063C67]). In addition, the adherent invasive *E*. *coli* strain LF82 induced severe colitis in ASF mice exposed to dextran sodium sulfate ([@DMM035063C36]). In the current study, ASF-colonized C3H/HeN mice were used to assess intestinal colonization and the host inflammatory response to non-pathogenic *E*. *coli* and EHEC inoculation. The objectives of this study were to: (1) determine the extent of *E*. *coli* colonization in the small and large intestine; and (2) compare the host intestinal response to EHEC versus non-pathogenic *E*. *coli* colonization.

RESULTS {#s2}
=======

Characterization of EHEC strain 278F2 {#s2a}
-------------------------------------

Major virulence genes intimin (*eae*) and Shiga toxin (*stx*) were tested for by using PCR assays. The clinical O157:H7 strain 278F2 was confirmed to be positive for both *eae* and Shiga toxin type 2 (*stx*~2~). EHEC strain 278F2 was further subtyped as Shiga toxin subtype 2a (*stx*~2a~)-positive by amplicon sequencing and VirulenceFinder analysis, and confirmed using subtype-specific primers ([@DMM035063C41]; [@DMM035063C62]).

Concentration of *E. coli* in ASF and CONV mice {#s2b}
-----------------------------------------------

To determine the ability of *E. coli* strains to colonize and persist in the GI tract of ASF and CONV mice, fecal samples were collected at 7, 14, 21 and 27 days post-inoculation, and intestinal contents were collected on day 28 post-inoculation ([Fig. 1](#DMM035063F1){ref-type="fig"}). All mice survived the length of the study and no *E*. *coli* was detected in uninfected ASF and CONV mice. Overall, *E*. *coli* strains were detected in the feces and consistently recovered from cecal and colonic contents of ASF mice at significantly higher (*P*\<0.05) concentrations compared to CONV mice ([Fig. 2](#DMM035063F2){ref-type="fig"}). Concentrations of EHEC strain 278F2 and non-pathogenic *E*. *coli* MG1655 isolated from fecal samples of ASF mice ranged from 10^6^ to 10^9^ CFU g^−1^ and were significantly higher (*P*\<0.05) on all days tested compared to CONV mice, which had levels ranging from not detected to 10^6^ CFU g^−1^. When comparing colonization levels within CONV mice, 278F2 was detected at significantly higher (*P*\<0.05) levels than MG1655 in feces on days 7, 14 and 21, but not on day 27. In CONV mice, 278F2 was detected in fecal samples from six to nine of 12 mice depending on the sampling day, while MG1655 was detected in only two of 13 CONV mice. In small-intestinal contents of ASF mice, 278F2 was significantly higher (*P*\<0.05) compared to 278F2 and MG1655 in CONV mice, with the exception of 278F2 in the ileum of CONV mice. In the cecum and colon of ASF mice, 278F2 and MG1655 were in quantifiable concentrations ranging from 10^4^ to 10^8^ CFU g^−1^ and were significantly higher (*P*\<0.05) than in CONV mice, which had *E*. *coli* at levels ranging from not detected up to 10^4^ CFU g^−1^. Fig. 1.**Timeline of experimental procedures.** Mice were inoculated with PBS (control) or 10^8^ CFU of enterohemorrhagic *E*. *coli* (EHEC) 278F2 or non-pathogenic *E. coli* MG1655. Weekly fecal samples were collected as indicted. The diet was changed to Teklad 2920X for fluorescent imaging and mice harboring the altered Schaedler flora (ASF; *n*=3 per group) were injected on day 27 post-inoculation with ProSense 680. At necropsy, the gastrointestinal (GI) tract was excised and imaged for mucosal inflammation (ASF mice only), intestinal contents were collected for enumeration of *E*. *coli* \[ASF and conventionally reared (CONV) mice\], and intestinal tissues were harvested (ASF mice only) for histopathology and host transcriptome profiling. Fig. 2.**Ability of *E. coli* to colonize mice harboring the altered Schaedler flora (ASF) or a conventionally reared (CONV) microbiota.** Mice were inoculated with 10^8^ CFU of pathogenic enterohemorrhagic *E*. *coli* (EHEC) strain 278F2 or non-pathogenic strain MG1655. The ability of strains to colonize the gastrointestinal tract was assessed by collecting (A) fecal samples on days 7, 14, 21 and 27 post-inoculation and (B-F) intestinal contents on day 28 post-inoculation. The sample size for each group was as follows: 278F2- or MG1655-inoculated ASF mice (*n*=13 or 10, respectively) and 278F2- or MG1655-inoculated CONV mice (*n*=12 or 13, respectively). Data are representative of at least two individual experiments. Each symbol represents an individual animal and bars indicate the mean. Blue and red symbols represent CONV and ASF mice, respectively. Means with the same letter are not significantly different (*P*\>0.05) as determined by an ANOVA followed by Tukey\'s test for multiple means comparison. The horizontal dashed line is the limit of detection (LOD). Samples that tested negative for *E*. *coli* were assigned a value halfway between zero and the LOD.

Body weight changes of ASF and CONV mice {#s2c}
----------------------------------------

Body weight was measured weekly and percentage change from that prior to oral gavage was calculated ([Table S1](Table S1)). Groups within day 7, 14, 21 and 27 were compared for mean body weight and mean percent change in body weight. *Escherichia coli* colonization did not cause any significant differences within groups of ASF or CONV mice, but CONV mice did gain significantly more weight (*P*\<0.05) compared to ASF mice. Colonization of ASF mice with 278F2 or MG1655 induced weight loss at day 7. However, the percent change in body weight of 278F2-inoculated versus uninfected ASF mice was not significantly different. *Escherichia coli* 278F2-inoculated ASF mice gained 3.4% and 5.7%, while uninfected ASF mice had an increase of only 1.9% and gained 3.0% on days 14 and 21, respectively.

Impact of *E*. *coli* strains on tissue damage in ASF mice assessed by histological grading {#s2d}
-------------------------------------------------------------------------------------------

Formalin-fixed intestinal tissue sections from uninfected and MG1655- or 278F2-colonized ASF mice were processed and scored for mucosal height, epithelial injury, inflammation and lesion presence. Summarized histological scores and measurements from five mice per group are shown in [Table 1](#DMM035063TB1){ref-type="table"}. No significant differences were found between groups of mice inoculated with different *E*. *coli* strains for histopathological scoring of ileal and colonic tissue. Colonic lesions were observed in one of five MG1655-colonized mice, displaying increased inflammatory cells, and two of five 278F2-colonized mice, with one exhibiting increased inflammatory cells and the other showing elongation of the glands ([Fig. S1](Fig. S1)). Table 1.**Histopathological evaluation of ileal and colonic tissue of ASF mice**

Evaluation of inflammation in the intestine of ASF mice {#s2e}
-------------------------------------------------------

To assess the effect of *E. coli* strains on mucosal inflammation, ASF mice were injected with ProSense 680, which is a fluorescent probe used to detect inflammation-associated protease activity. Heat-map images of the GI tract from uninfected or *E*. *coli-*colonized mice were generated and analyzed for total corrected cellular fluorescence (TCCF) ([Fig. 3](#DMM035063F3){ref-type="fig"}). Mucosal inflammation in ASF mice colonized with 278F2 was significantly higher (*P*=0.03) than in MG1655-colonized mice in the cecum ([Fig. 3](#DMM035063F3){ref-type="fig"}B). No significant differences were found between groups for the stomach, small intestine or colon. However, ASF mice colonized with 278F2 had numerically higher mucosal inflammation levels compared to both uninfected and MG1655-colonized mice in all regions tested. Fig. 3.**Evaluation of mucosal inflammation in mice with a microbiota consisting of the altered Schaedler flora (ASF).** Mice received a tail vein injection with 2 nmol per mouse of ProSense 680 and were imaged 18 h later using the In Vivo Multispectral Imaging System FX Pro. (A) The entire GI tract was excised from uninfected (top row), non-pathogenic *E. coli* MG1655-inoculated (middle row), and enterohemorrhagic *E*. *coli* (EHEC) 278F2-inoculated (bottom row) mice (*n*=3 per group). Arrows indicate the cecum. (B) Relative fluorescence was measured in ImageJ. An ANOVA followed by Tukey\'s method for multiple means comparison was used to compare total corrected cellular fluorescence of intestinal sections. Each symbol represents an individual animal and bars represent mean±s.e.m.

Comparison of cytokine levels released from colonic biopsies {#s2f}
------------------------------------------------------------

The levels of interleukin (IL)-1β, IL-12, interferon gamma (IFNγ) and tumor necrosis factor alpha (TNFα) released from colonic explants was assessed to determine whether *E*. *coli* strains elicited a proinflammatory environment. For colon biopsies of 278F2 inoculated ASF and CONV mice, cytokine levels were numerically higher than uninfected mice, but were not significantly different (*P*\>0.05) ([Fig. S2](Fig. S2)). IL-12 was significantly higher (*P*\<0.05) in biopsies of MG1655-inoculated CONV mice compared to uninfected mice.

Comparison of inflammatory-associated gene expression and protein-protein interactions in the colon of ASF mice {#s2g}
---------------------------------------------------------------------------------------------------------------

To further characterize the host response to colonization with *E*. *coli* strains, a targeted gene expression panel was used to identify differentially expressed genes (DEGs) between ASF mice uninfected or infected with different strains of *E. coli*. The colon was selected because it is the major site of *E*. *coli* colonization in humans; the highest levels of 278F2 and MG1655 were recovered from the colon of mice in the present study ([Fig. 2](#DMM035063F2){ref-type="fig"}), and some mice exhibited colonic lesions ([Fig. S1](Fig. S1); [Table 1](#DMM035063TB1){ref-type="table"}). High-quality RNA was used for RNA-seq, with an average RNA integrity number of 9.1 ([Table S2](Table S2)). The results of gene expression in the colon for the comparisons of uninfected versus MG1655-colonized, uninfected versus 278F2-colonized and MG1655-colonized versus 278F2-colonized ASF mice are found in [Table 2](#DMM035063TB2){ref-type="table"}. Twenty-seven DEGs were detected in the comparison of MG1655-colonized versus uninfected mice, with 23 upregulated and four downregulated genes. Eighteen DEG were detected in the comparison of 278F2-colonized versus uninfected mice, with 13 upregulated and five downregulated. Five genes were differentially expressed in both 278F2- and MG1655-colonized mice compared to the uninfected group. Of these five genes, three (*Cxcl9*, *Il17f* and *Inhba*) were upregulated in both 278F2- and MG1655-colonized mice, while the two remaining DEGs (*Cebpa* and *Cxcl10*) were inversely regulated relative to each other. For the comparison of 278F2- versus MG1655-colonized ASF mice, 17 DEGs were detected, with ten upregulated and seven downregulated. The largest fold-change increase was in Fc receptor, IgE, high affinity I, alpha polypeptide (*Fcer1a*) and the largest decrease was identified in urotensin 2 (*Uts2*). Table 2.**Differentially expressed inflammatory-associated genes in the colon**

In the protein-protein interaction network comparisons of uninfected versus MG1655-colonized ([Fig. 4](#DMM035063F4){ref-type="fig"}A) and uninfected versus 278F2-colonized ASF mice ([Fig. 4](#DMM035063F4){ref-type="fig"}B), the strongest clustering was between the chemokine ligands, with six chemokines in each cluster per comparison. The former revealed Il2rb as a hub, with connections to eight other proteins ([Fig. 4](#DMM035063F4){ref-type="fig"}A), and the latter revealed Lep as a hub, with connections to four other proteins ([Fig. 4](#DMM035063F4){ref-type="fig"}B). In the comparison of 278F2- versus MG1655-colonized ASF mice ([Fig. 4](#DMM035063F4){ref-type="fig"}C), the chemokine cluster was smaller than the other comparisons and only contained three proteins (Ccl1, Ccl20 and Ccr8). The Ccl20 protein had connections to five other proteins, making it the biggest hub for the comparison of MG1655- versus 278F2-colonized ASF mice. Fig. 4.**Protein-protein interaction network among differentially expressed genes (DEGs) in colon tissue of altered Schaedler flora (ASF) mice.** DEGs from the comparisons of (A) uninfected vs MG1655-colonized, (B) uninfected vs 278F2-colonized and (C) MG1655-colonized vs 278F2-colonized ASF mice were used as input for protein-protein interactions. The edges connecting proteins represent the predicted functional associations and are colored based on the type of interaction.

DISCUSSION {#s3}
==========

*Escherichia coli* is one of the best-understood microorganisms, but we know little about its impact on the intestine and which microbe-microbe interactions influence colonization *in vivo*. To study *E*. *coli* in the GI tract, ASF mice harboring a stable eight-member microbiota were characterized for: colonization compared to CONV mice, mucosal inflammation and expression of inflammatory-associated genes after colonization with a pathogenic or non-pathogenic *E*. *coli* strain. Stable colonization of ASF mice was achieved using a single gavage of 10^8^ CFU ([Fig. 2](#DMM035063F2){ref-type="fig"}). Concentrations of both strains increased along the GI tract, as assessed from the duodenum to the colon, in ASF mice ([Fig. 2](#DMM035063F2){ref-type="fig"}), similar to that observed in humans ([@DMM035063C61]). It is difficult to directly compare our study with other mouse models, as varying bacterial and mouse strains, mouse age, microbiota, and inoculum concentration likely contribute to reported differences in *E. coli* colonization. Earlier studies have used MG1655 as a non-pathogenic *E*. *coli* to study colonization of streptomycin-treated mouse models ([@DMM035063C17]; [@DMM035063C28]; [@DMM035063C47]). In those studies, MG1655 and the EHEC strain EDL933 were found to occupy distinct nutritional niches in the mouse intestine ([@DMM035063C17]). Although MG1655 lacks many of the virulence and colonization factors found in EHEC, it may be able to persist in ASF mice due to an open nutritional niche. Future studies could explore the open nutritional niches found in ASF mice that are not found in CONV mice. Although the use of CONV mice is advantageous for assessing interaction and competition with a complex microbiota, we found that some CONV mice were not colonized by 278F2 ([Fig. 2](#DMM035063F2){ref-type="fig"}A) and only two CONV mice had consistent recovery of MG1655 in feces ([Fig. 2](#DMM035063F2){ref-type="fig"}A) using our method of detection. In a different study using CONV mice, inoculation with approximately 10^9^ CFU of EHEC resulted in rapidly reduced levels (3-4 log~10~) within 24 h ([@DMM035063C53]). In another study using CONV mice, inoculation with a higher level (10^10^ CFU) resulted in similar clearance of EHEC, and a shedding duration of only 2 weeks was observed for most mice ([@DMM035063C16]). While it is unclear how long ASF mice could be colonized, we showed that these mice shed *E*. *coli* for at least 1 month ([Fig. 2](#DMM035063F2){ref-type="fig"}), which mimics the mean duration of O157 EHEC shedding in children under 5 years old ([@DMM035063C51]; [@DMM035063C56]; [@DMM035063C63]).

It is thought that facultative anaerobes in CONV mice inhibit growth of invading *E*. *coli* strains. Therefore, streptomycin treatment is commonly used to suppress facultative anaerobes to allow *E*. *coli* to overcome colonization resistance in mice ([@DMM035063C13]; [@DMM035063C47]; [@DMM035063C52]). The exact mechanism of reduction of colonization resistance after streptomycin administration is unclear, but elimination of microbe-microbe interactions and a streptomycin-induced inflammatory response to support growth of *E*. *coli* through nitrate respiration has been suggested ([@DMM035063C66]). A limitation of using spontaneous streptomycin-resistant *E*. *coli* strains is that they may have slight to significant decreases in colonization factor expression that could influence host-pathogen interactions ([@DMM035063C13]). In addition, streptomycin treatment alone leads to a modest increase in histopathological changes, making the intestine more irritable ([@DMM035063C66]). Germ-free mouse models have also been used ([@DMM035063C30]; [@DMM035063C71]), but these models lack the ability to assess microbe-microbe interactions and have underdeveloped mucosal immune systems ([@DMM035063C38]). Thus, ASF mice serve as an alternative to germ-free and streptomycin-treated models, and can be used to assess inflammatory changes without the use of a confounding antibiotic treatment.

Inflammation in the GI tract plays a key role in defending against pathogens. Bacterial components such as endotoxin, flagellin and Shiga toxin can stimulate the inflammatory response during EHEC infection ([@DMM035063C57]). The concentrations of common proinflammatory markers, including IL-1β, IL-12, IFNγ and TNFα, were numerically greater in colon supernatants of EHEC-inoculated mice compared to uninfected mice ([Fig. S2](Fig. S2)), but no significant differences were found. These results indicate that other factors may account for intestinal inflammation observed in this system. However, IL-12 was significantly higher (*P*\<0.05) in supernatants of MG1655-inoculated CONV mice compared to uninfected mice. IL-12 is produced by dendritic cells and macrophages in response to microbial products binding to Toll-like receptors ([@DMM035063C74]). In addition, mucosal inflammation was assessed using a technique that relied on injection of an imaging agent that is activated in the presence of inflammation-associated proteases such as cathepsin B, K, L and S. Here, elevated levels of mucosal inflammation were found in the cecum of 278F2- compared with MG1655-colonized ASF mice ([Fig. 3](#DMM035063F3){ref-type="fig"}), which is consistent with gene expression data showing increased chemokine expression (e.g. *Ccl20*) that could recruit macrophages to the mucosa. Although both the cecum and colon had high levels of EHEC, previous studies have found that EHEC closely associates with the cecal epithelium and not the colon in mice ([@DMM035063C20]; [@DMM035063C59]). This possibility may account for why a significant difference was observed only in the cecum. Previously, cathepsin B release was shown in EHEC-infected human monocytes but could not be demonstrated using mouse monocytes ([@DMM035063C14]). This suggests that other cathepsins may be released or other cell types may release cathepsin B in the mouse during EHEC infection. The presence of cathepsins, primarily macrophage enzymes, at 28 days post-inoculation indicates elicitation of chronic inflammation. Infectious gastroenteritis caused by zoonotic pathogens has been proposed as a risk factor in the 'multi-hit' model of inflammatory bowel disease ([@DMM035063C32]; [@DMM035063C65]). Thus, both the acute infection phase and the chronic impact of GI inflammation pose risks to human health. To counteract inflammation, EHEC releases effector proteins ([@DMM035063C57]). EHEC strains inhibit NF-κB activity in a type-III-secretion-system-dependent manner ([@DMM035063C34]). Previously, multiple non-LEE effector proteins were found to interfere with innate immune system signaling pathways ([@DMM035063C27]; [@DMM035063C54]). Thus, while host cells may recognize microbial factors and activate inflammatory pathways to eliminate the pathogen, EHEC uses strategies to interfere with these signals to survive in the inflamed intestine.

Various levels of disease, from no apparent change to death, have been reported in *E*. *coli-*colonization mouse models. In the current study, only modest histopathological changes such as increased inflammatory cells and elongation of the glands were identified ([Fig. S1](Fig. S1), [Table 1](#DMM035063TB1){ref-type="table"}), and no mice died. Colonic lesions have been found in other mouse models of EHEC infection ([@DMM035063C5]; [@DMM035063C10]) and were most thoroughly described in a germ-free model ([@DMM035063C21]). Previous studies using EHEC mouse models have noted weight loss ([@DMM035063C53]) but, in the current study, only a slight initial decrease was observed for MG1655- and 278F2-colonized ASF mice ([Table S1](Table S1)). In addition, both ASF and CONV mice inoculated with 278F2 gained weight on all but 7 days post-inoculation. Changes in inflammatory-associated genes that are also linked to metabolic processes, such as adiponectin, leptin and thrombopoietin, indicate that metabolic processes were modulated after chronic colonization with 278F2, which may account for the gain in body weight. CONV mice had significantly greater changes in body weights compared to ASF mice on 21 and 27 days post-inoculation, except for 278F2-colonized ASF mice on day 21. Previously, [@DMM035063C3] found that CONV mice had significantly higher body fat content compared to germ-free mice, suggesting that microbiota influences weight gain. In addition to differences in weight gain, oral inoculation with O157 EHEC has been lethal in some mouse models. In one study, 40% of C3H/HeN mice died after intragastric inoculation with 10^8^ CFU of EHEC O157:H7 ([@DMM035063C44]). In another study, 100% of immature BALB/c mice died within 24 h using an inoculum of 10^10^ CFU kg^−1^ ([@DMM035063C10]). Death was likely due to translocation of Shiga toxin into the systemic circulation after intestinal tissue damage in these lethal models. Therefore, mature ASF mice can be used as a stable non-lethal model in future studies to assess the efficacy of vaccines for reducing fecal shedding of EHEC and further explore microbe-microbe interactions.

ASF mice have not been exposed to *E*. *coli* or any other Proteobacteria, allowing for the first interactions between *E*. *coli* and host to be studied. A targeted approach (*N*=500 genes) was used to characterize the effect of prolonged *E*. *coli* colonization on host gene expression in the colon. To our knowledge, this is the first study to characterize a large set of inflammatory-associated genes in response to EHEC colonization in a mouse model. Most studies have focused on bacterial gene expression, while those targeting host expression have been limited to human cell lines infected for less than 24 h ([@DMM035063C6]; [@DMM035063C12]; [@DMM035063C39]; [@DMM035063C40]; [@DMM035063C45]; [@DMM035063C46]). In the current study, colons were removed 28 days after inoculation to mimic the average duration of O157 EHEC shedding in children. EHEC colonization produced a distinct gene expression pattern ([Table 2](#DMM035063TB2){ref-type="table"}), which was expected considering the large differences between non-pathogenic *E*. *coli* K-12 and O157 EHEC strains ([@DMM035063C35]). In the comparison between 278F2- and MG1655*-*colonized ASF mice, 41% of the DEGs were downregulated, including cytokines *Ccl1*, *Ifnk* and *Ppbp* and cytokine receptor *Ccr8*, giving insight into mechanisms used by 278F2 to modulate host immunity ([Table 2](#DMM035063TB2){ref-type="table"}). Another downregulated gene, *Gzmb*, is involved in apoptosis of infected cells, which may be an important aspect in the ability of EHEC to evade host immunity. Increased expression of cytokines (*Bmp2*, *Ccl20*, *Il18*, *Il23a*) in 278F2- compared to MG1655-colonized mice was consistent with increased inflammation observed histologically and by intestinal imaging after ProSense injection. Future studies may use RNA-seq to characterize the host transcriptome, which includes all genes rather than those already known to be involved in immunity. Also, subsequent studies could use RNA-seq to compare ASF to CONV mice to determine how microbiota impacts host response after *E*. *coli* inoculation. Furthermore, understanding global gene expression patterns in the intestine that are affected by *E*. *coli* may be increasingly important, as early infant colonization with commensal *E*. *coli* has recently declined in Western countries ([@DMM035063C1]; [@DMM035063C22]).

Protein-protein interactions are at the core of cellular responses, including response to infection. In the current study, chemokine interactions were the largest networks in all comparison groups, likely due to their myriad of functions during infection, e.g. chemotaxis, and leukocyte activation and extravasation ([@DMM035063C49]). In 278F2- compared to MG1655-colonized mice, the clustering showed interesting predictions for mechanisms of downregulation during EHEC infection. The downregulated DEGs *Ccl1*, *Ccr8* and *Ppbp* were all associated in the protein network ([Fig. 4](#DMM035063F4){ref-type="fig"}A). Previous research has shown that Ccl1 and Ccr8 are co-expressed in macrophages ([@DMM035063C69]). Furthermore, Ppbp is predicted to activate expression of Ccr8 via binding based on pathway neighbor associations ([@DMM035063C42]). Interestingly, the *Ppbp* gene was highly upregulated (fold change=14.9) in the comparison of MG1655 versus uninfected, but highly downregulated (fold change=0.2) in 278F2- versus MG1655-colonized mice. We hypothesize that regulation of the *Ppbp* gene by EHEC is a potential method used for host evasion. Future research should further characterize this interaction.

In summary, we were able to demonstrate reliable and prolonged colonization of ASF C3H/HeN mice with both a pathogenic and non-pathogenic strain of *E*. *coli*. This system can be explored in future studies to dissect the interplay between *E. coli* and members of the intestinal microbiota. Gene expression analysis showed that EHEC strain 278F2 had a modest effect on the inflammatory response in the colon of ASF mice by differentially modulating 17 genes compared to MG1655-colonized mice. Overall, these results indicate that the low-complexity ASF microbiota allowed for prolonged intestinal colonization by pathogenic and non-pathogenic strains of *E*. *coli*, and host inflammatory processes were modulated.

MATERIALS AND METHODS {#s4}
=====================

Ethics statement {#s4a}
----------------

Animal experiments were carried out in accordance with the recommendations by the Guide for the Care and Use of Laboratory Animals. All experiments were performed under the approval and requirements of the Iowa State University Institutional Animal Care and Use Committee (protocols 9-04-5755-M and 1-16-8157-M). Mice were acclimated for at least 2 days before each experiment. Humane endpoint criteria were set such that any moribund animals, animals unable to feed or drink, and any animal that had greater than 10% body weight loss were euthanized immediately by carbon dioxide inhalation.

Bacterial strains and inoculation {#s4b}
---------------------------------

The non-pathogenic *E*. *coli* K-12 strain MG1655 ([@DMM035063C8]) and O157:H7 EHEC strain 278F2 isolated from a human patient ([@DMM035063C23]) obtained from Dr Jorge Girón (University of Virginia) were used throughout this work. The EHEC strain 278F2 was typed for *stx* and *eae* genes by PCR ([@DMM035063C4]; [@DMM035063C7]), and further subtyped by amplicon sequencing and VirulenceFinder version 1.5 analysis and subtype-specific primers ([@DMM035063C41]; [@DMM035063C62]). EDL933 was used as a positive control and water was used as a negative control in PCR assays. Bacterial strains were streaked on trypticase soy agar from stock cultures (−80°C) and incubated overnight at 37°C. A loopful of culture was inoculated in 3 ml of PBS until OD~600~ reached 1.0. Bacterial suspensions were diluted twofold in PBS and 0.2 ml (1×10^8^ CFU) was used for a single inoculation of mice intragastrically via oral gavage (*n*=10-13 mice per group). Dilutions of the bacterial cultures were plated on MacConkey agar to confirm the actual inoculum.

Mice {#s4c}
----

Male and female C3H/HeN mice (12- to 15-weeks old) with a defined microbiota consisting of the ASF (originally from Taconic Biosciences, Germantown, NY) were maintained as described previously ([@DMM035063C36]). Briefly, C3H/HeN ASF mice were bred and maintained in flexible film isolators under gnotobiotic conditions following established pathogen-free husbandry practices. The ASF community has been consistently transmitted from dam to offspring and has stably colonized C3H/HeN mice for over 15 years at Iowa State University. Periodically, fecal samples have undergone 16S rRNA gene sequencing as an additional measure to ensure stability of the ASF members ([@DMM035063C77]). C3H/HeN mice (12- to 15-weeks old) with a CONV microbiota were purchased from Taconic Biosciences. All inoculation and handling procedures were done with sterile instruments in a biosafety cabinet. Mice were provided an irradiated diet (Teklad 2919), autoclaved water, and a 12-h light-dark cycle was used. Animals were monitored daily for diarrhea and changes in behavior, and body weights were measured weekly. At the end of the study, mice were euthanized by carbon dioxide inhalation.

Quantification of *E*. *coli* in feces and intestinal contents from ASF and CONV mice {#s4d}
-------------------------------------------------------------------------------------

Fecal samples were collected weekly over 4 weeks to determine the level of *E*. *coli* shed. Before inoculation, fecal samples were collected from ASF and CONV mice to confirm *E. coli* negative status. After 4 weeks, mice were euthanized, and contents from the duodenum, jejunum, ileum, cecum and colon were collected. To quantify *E*. *coli*, samples were weighed, homogenized in PBS, serially tenfold diluted, and plated on MacConkey agar. Concentration was determined based on CFU g^−1^ of feces or intestinal content.

Histopathology on intestinal sections from ASF mice {#s4e}
---------------------------------------------------

Samples of the distal ileum and proximal colon (*n*=5 per group) from randomly selected ASF mice were fixed in 10% neutral buffered formalin, dehydrated through a graded alcohol and xylene series, embedded in paraffin, sectioned 5 μm thick, and stained with Hematoxylin and Eosin. Stained tissue sections were examined by a board-certified veterinary pathologist blinded to the identity of the sample. Tissues were evaluated for mucosal height and scored for epithelial injury and inflammation using a rising 5-step scale with the following criteria: 0, parameter is absent; 1, parameter is present at a low level; 2, parameter is mildly increased; 3, parameter is moderately increased; 4, parameter is severe; 5, parameter is so severe that normal architecture of the tissue is distorted or lost. Binary classification was used to describe the presence or absence of lesions observed in a given intestinal segment. Mucosal height was measured as a ratio of the length to width of the glands and only in regions of the tissue where orientation allowed for full longitudinal sections of the colonic glands to be evaluated.

Mucosal inflammation in ASF mice {#s4f}
--------------------------------

To assess mucosal inflammation, 4 days before necropsy the diet of randomly selected ASF mice (*n*=3 per group) was changed to an irradiated soy-protein-free extruded diet recommended for fluorescent optical imaging (Teklad 2920X) due to the lack of fluorescent plant material (e.g. chlorophyll). On day 27, ASF mice were injected with ProSense 680 synthesized as previously described ([@DMM035063C11]) and imaged approximately 18 h later. ProSense 680 is a near-infrared fluorescent agent that is optically silent but, in the presence of cathepsins (primarily cathepsins B, K, L and S), is cleaved at lysine-lysine sites, which in turn releases fluorophores from quenching (PerkinElmer, Waltham, MA). ProSense 680 has been validated to detect acute and chronic colonic inflammation in mice ([@DMM035063C19]). The entire GI tract (stomach to rectum) was excised and images were generated using a live-animal imager (In Vivo Multispectral Imaging System FX Pro, Bruker, Billerica, MA) with a 1-min exposure and excitation and emission wavelengths of 650 and 700 nm, respectively. Images were analyzed in ImageJ with white set at a value of 0 and black a value of 65,535. An outline was drawn around each section of the intestine (stomach, small intestine, cecum or large intestine) and TCCF was measured as described previously ([@DMM035063C50]).

Evaluation of cytokine levels in colon samples from ASF and CONV mice {#s4g}
---------------------------------------------------------------------

Collection of colon tissues and processing was performed as previously described ([@DMM035063C36]). Briefly, a 1 cm^2^ colon tissue biopsy was collected from ASF and CONV mice (*n*=4 per group), placed in PBS to remove intestinal contents and transferred to a tube containing RPMI plus gentamicin (50 μg ml^−1^), penicillin (200 IU ml^−1^) and streptomycin (200 μg ml^−1^) at room temperature with shaking at 280 rpm. After 30 min, tissues were transferred to 96-well plates containing RPMI plus gentamicin (50 μg ml^−1^), penicillin (200 IU ml^−1^), streptomycin (200 μg ml^−1^), L-glutamine (2 mM), 2-mercaptoethanol (0.05 mM) and pyruvate (1 mM), and incubated at 37°C in 5% CO~2~. After 24 h, supernatants were harvested and frozen at −20°C until further use. Levels of proinflammatory markers IL-1β, IL-12, IFNγ and TNFα were assessed using a multiplex bead assay and Bio-Plex 200 multiplex reader (Bio-Rad, Hercules, CA).

Eukaryotic total RNA isolation from ASF mouse colonic tissue {#s4h}
------------------------------------------------------------

Samples randomly selected from uninfected, MG1655-inoculated and 278F2-inoculated ASF mice (*n*=3 per group) were used for RNA isolation. Total RNA was isolated from a dissected section of the proximal colon approximately 3 cm in length that was perforated and immersed in RNAlater (Ambion) overnight at 4°C. The next day, tissues were removed from RNAlater and stored at −80°C until further use. Tissues were homogenized for 1 min on high in a stomacher and RNA was extracted using the RNeasy Mini Kit (Qiagen). RNA integrity and concentration were assessed using the Agilent 2100 Bioanalyzer, and samples with an RNA integrity number greater than 7 were used for RNA-seq.

Mouse inflammation panel {#s4i}
------------------------

The isolated RNAs were sequenced on the Mouse Inflammation and Immunity Transcriptome QIAseq Targeted RNA panel (Qiagen) assaying 500 genes associated with inflammation. Count data were generated using the QIAseq Targeted RNA Panel Analysis software. Data were normalized and DEGs were determined for the contrasts between (i) uninfected versus non-pathogenic *E. coli*, (ii) uninfected versus EHEC, and (iii) non-pathogenic *E. coli* versus EHEC, using EdgeR software with default parameters with a significance threshold *P*-value\<0.05 and fold-change cutoffs \<0.5 and \>1.5 ([Table S3](Table S3)). Protein-protein interaction networks were created in the program STRING ([@DMM035063C70]) with default parameters using DEG lists within each contrast as input data.

Statistical analysis {#s4j}
--------------------

All data were analyzed using GraphPad Prism version 6 software. An ANOVA followed by Tukey\'s test for multiple comparisons was used to compare colonization levels in fecal and intestinal samples, intestinal inflammation in ASF mice, mean body weight changes, and levels of cytokines released from colonic biopsies. The Kruskal--Wallis test was used to compare histopathology scores and Fisher\'s exact test (two-tailed) was used to compare proportion of tissues positive for lesions. *P*-values\<0.05 were considered significant.
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